Bluejay Diagnostics, Inc. (BJDX:NASDAQ) closed at $0.779 on October 15, 2026, down 1.03% on the day. The stock trades 94.3% below its 52-week high of $13.64 and 3.2% above its 52-week low of $0.755. Over the past year, it lost 93.4%. Bluejay Diagnostics, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -1.63% | -4.15% | -35.60% | -60.44% | -93.37% |
In 252 trading sessions since October 15, 2025, BJDX closed higher on 92 days (37%). Its best day was June 2, 2026 (+100.00%) and its worst was June 29, 2026 (-50.85%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 4 times.
Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide convenience, timeliness, compliance and low cost to physicians and patients in areas where timeliness of the initial triage assessment has a high impact on course of treatment.
Find more stocks like BJDX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.